Y-Intercept (HK)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,395
Closed -$784K 1862
2025
Q4
$784K Buy
+1,395
New +$792K 0.02% 1088
2025
Q3
Sell
-3,762
Closed -$1.18M 1847
2025
Q2
$1.18M Buy
+3,762
New +$1.13M 0.03% 858
2024
Q4
Sell
-8,430
Closed -$2.81M 1470
2024
Q3
$2.81M Buy
+8,430
New +$3.2M 0.17% 134
2023
Q4
Sell
-7,639
Closed -$1.85M 1482
2023
Q3
$1.85M Buy
+7,639
New +$1.95M 0.18% 155
2021
Q1
Sell
-2,118
Closed -$292K 724
2020
Q4
$292K Buy
+2,118
New +$267K 0.12% 315

Other funds holding MEDP

Y-Intercept (HK)'s MEDP Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,395 shares — an estimated $784K sold.

Y-Intercept (HK) first reported a position in MEDP in Q4 2020 and held it in 5 quarters. The position peaked at $2.81M in Q3 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 1,395 Medpace shares in Q1 2026, an estimated $784K.
  • Y-Intercept (HK) first reported a position in Medpace in Q4 2020 and held it in 5 quarters.
  • Y-Intercept (HK)'s Medpace position peaked at $2.81M in Q3 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.